|
Ginkgolides reduce prostaglandin E2 production: Levels of prostaglandin E2 produced by untreated SH-SY5Y cells, or cells pre-treated with 1 μM ginkgolide A, 1 μM ginkgolide B, 25 μM myricetin or 25 μM quercetin and thereafter incubated for 24 hours with 10 μM arachidonic acid, 10 μM amyloid-β1-42 10 μM HuPrP82-146 or 5 μM PAF. Each value is the mean level of prostaglandin E2 (pg/ml) ± SD from triplicate experiments repeated three times (9 observations). |
|||||
| untreated |
HuPrP82-146 |
amyloid-β1-42 |
arachidonic acid |
PAF |
|
|
|
|||||
| Medium |
<20 |
362 ± 46 |
323 ± 39 |
438 ± 55 |
157 ± 38 |
| ginkgolide A |
<20 |
66 ± 40** |
57 ± 40** |
234 ± 34** |
45 ± 29** |
| ginkgolide B |
<20 |
<20** |
25 ± 27** |
145 ± 30** |
36 ± 26** |
| myricetin |
<20 |
358 ± 64 |
327 ± 36 |
450 ± 30 |
149 ± 28 |
| quercetin |
<20 |
349 ± 51 |
319 ± 28 |
442 ± 45 |
169 ± 29 |
|
** = Prostaglandin E2 production significantly less (p < 0.05) than in untreated cells. | |||||
Bate et al. Journal of Neuroinflammation 2004 1:4 doi:10.1186/1742-2094-1-4 |
|||||